NCCN Guidelines for Risk Management for Men with BRCA mutations
Breast self-exam training and education beginning at age 35
Annual clinical breast exam beginning at age 35
Prostate cancer screening for BRCA2 mutation carriers beginning at age 45 is recommended, and should be considered for BRCA1 mutation carriers. Screening consists of a blood test known as PSA and strong recommendation for a clinical digital rectal exam.
Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.